Geneva Cancer Registry

This interactive dashboard serves as a living observatory of cancer in Geneva's canton, enabling patients, clinicians, researchers and policymakers to quickly explore up-to-date incidence and mortality indicators by tumour site, gender, year.

Each year in Geneva: *

Data extraction date: 10.08.2026
Application update date: 10.08.2026

Overall epidemiology

Note: non-melanoma skin cancers (C44) are excluded from this summary page, and figures apply IARC multiple primary rules (one tumour counted per organ/site per patient).


The Others category is kept in tables and CSV exports but is not shown as a separate bar in this chart.

: fewer than 5 cases observed over the chosen period; aggregated data masked to protect patient privacy.
Cancer sites with fewer than 5 total cases over the selected period (for the selected sex) are merged into the Others category. This threshold is based on total cases, not on annual averages.

Cancer sites with fewer than 5 total cases over the selected period (for the selected sex) are merged into the Others category. This threshold is based on total cases, not on annual averages.
Cancer sites with fewer than 5 cases in any year of the selected period (for the selected sex) are merged into Others for all years. For consistency with Top N selection, sites ranked in the Top N of the latest selected year remain displayed as separate bands.

Counts below 5 in any table cell are displayed as "—" (em dash), consistent with other tables. Sites merged into Others follow the chart rule above.

Age groups with fewer than 5 cases over the entire period are not displayed in the chart (bars are omitted).

Age groups with fewer than 5 cases over the entire period are displayed as "-" in the table.

Note: Only cancer sites with at least 5 cases for each period are included.



Important : evolution shown only if the selected site has at least 5 cases in each 3-year period (for the selected sex).


: fewer than 5 cases observed over the chosen period; aggregated data masked to protect patient privacy.

Important : trends are shown when yearly counts meet the official 5-case rule, with tolerance for at most 3 years below 5 over the selected period (for the selected sex). Joinpoint estimates remain visible in the table/export for interpretation.


Note: Points are hidden when fewer than 5 cases are observed in the 3-year period for the selected age group.


⚠ Important: The APC assumes linear trends between the two periods. Interpret with caution if trends are non-linear.


Note: APC models require sufficient cases across age and period cells. Results should be interpreted together with the deviance table.



Model comparison (deviance table)


Input table (cases and person-years)

Note: Observed age-specific rates are plotted against year of birth (period minus age). This descriptive view does not estimate an APC model.


In this animated chart, Others is hidden from bars for readability. The category remains available in related tables/exports when applicable.

This page provides a concise overview of the cancer burden in Geneva through key incidence and mortality indicators for each selected cancer site, considered independently from the others.

Key Indicators

Cancer site
Incidence (invasive)
Mortality
Mortality-to-Incidence Ratio (MIR)
population-level lethality proxy
0% (favourable) 100% (unfavourable)
Incidence profile
Median age at diagnosis
Mortality profile
Median age at death
Incidence rate
Mortality rate
Mean annual incidence counts
Peak age group
Share aged <50
Mean annual mortality counts
Peak age group
Share aged <65
Explore Geneva cancer data

More detailed information for each cancer type will be available soon.

Multiple primaries (Incidence)



Note: Original cases (recording) count all registered tumours. Included cases (reporting) exclude multiple primary tumours according to IARC rules. Values are aggregated over 5-year periods.